B01J13/206

METHOD FOR PREPARING MULTILAYER SPHERICAL PARTICLES AND COSMETIC COMPOSITION COMPRISING MULTILAYER SPHERICAL PARTICLES PREPARED THEREBY

The present invention relates to a method for preparing multilayer spherical particles and, more specifically, to a method for preparing multilayer spherical particles comprising the steps of: (i) preparing a core component comprising an active ingredient and a shell solution comprising a first polymer component; (ii) forming the core component and shell solution of step (i) into core-shell particles by electro-coextrusion; (iii) drying the core-shell particles obtained from step (ii); and (iv) capsulizing the dried core-shell particles of step (iii) by means of a second polymer. Further, the present invention relates to a cosmetic composition comprising multilayer spherical particles prepared by the method.

SYSTEM, METHOD, AND APPARATUS RELATING TO COLLOIDOSOMES

An ultra low density film and an ultra low density solid material are produced by the steps of providing a vessel, introducing two immiscible fluids into the vessel, adding nanocrystals to at least one of the two immiscible fluids, applying a shear force to the two immiscible fluids and the nanocrystals in a manner that causes the nanocrystals to self-assemble and form colloidosomes. The colloidosomes amass and evaporation of the two fluids produces dried colloidosomes. The ultra low density self-assembled colloidosomes are hollow self-assembled colloidosomes, which are formed into the ultra-low density film and the ultra-low density solid.

FORMATION OF PARTICLES INCLUDING AGENTS

The invention provides methods for the preparation of particles including one or more agents, e.g., therapeutic or diagnostic agents. The particles can be formed by creating droplets of a first liquid, e.g., including an agent, and removing the first liquid, e.g., through its dispersal in a second liquid and/or evaporation, to solidify the droplets. Advantageously, the process of forming the particles does not significantly alter the structure or activity of the agents and may enhance the stability of the agents. For example, the particles may be stored for long periods of time without significant loss of activity, and in some embodiments, without the need for refrigeration. These particles may be used to generate stabilized pharmaceutical compositions for storage or other logistical purposes, pharmaceutical suspensions, pharmaceutical powder formulations (e.g., inhalable powders, injectable powders), creams or other topical pastes, nutraceuticals, or cosmetics.

COMPOSITIONS CONTAINING A HOLLOW GLUCAN PARTICLE OR A CELL WALL PARTICLE ENCAPSULATING A TERPENE COMPONENT, METHODS OF MAKING AND USING THEM
20200236927 · 2020-07-30 ·

The present invention relates to compositions comprising a hollow glucan particle or cell wall particle encapsulating a terpene component, methods of their manufacture and their use. The compositions are suitable for preventing and treating infections in plants and animals, including humans.

Encapsulated perfume compositions

An encapsulated perfume composition comprising at least one perfume-containing aminoplast core-shell microcapsule dispersed in an aqueous suspending medium, the microcapsule being characterized in that it bears a positive charge.

PROCESS FOR DRYING A SUSPENSION OF HYDROGEL MICROCAPSULES

Described herein is a new process for the preparation of powdered microcapsules encapsulating active volatile active ingredients, in particular a perfume or a flavour, the process being performed at room temperature. Powdered microcapsules obtainable by the process are also described. Perfuming and flavouring compositions as well as consumer products including the capsules are also described.

Incorporation of chitosan in microcapsule wall
20200222873 · 2020-07-16 · ·

The microcapsules and process of making describe a novel core shell microcapsule. The microcapsule incorporates a polysaccharide such as chitosan into the microcapsule wall forming the shell. The microcapsule shell is formed by dissolving chitosan into a material of structure

##STR00001##

wherein each R is independently selected from hydrogen, C.sub.1 to C.sub.8 alkyl, or a cyano group; and each y is independently an integer from 1 to 8, and reacting with a multifunctional (meth)acrylate.

Granules

Plurality of granules comprising a ceramic core having an outer surface and a shell on and surrounding the core, wherein the shell comprises ceramic particles bound together with an inorganic binder, the inorganic binder comprising reaction product of at least alkali silicate and hardener, wherein the ceramic particles are present as greater than 50 percent by weight of the shell of the respective granule, based on the total weight of the shell of the respective granule, wherein the shell of each granule has a total porosity in a range from greater than 0 to 60 percent by volume, based on the total volume of the shell of the respective granule, wherein the shell of each granule has a volume of at least 40 volume percent, based on the total volume of the respective granule, and wherein the granules have a minimum Total Solar Reflectance of at least 0.7. The granules are useful, for example, as roofing granules.

IMPROVED MICROCAPSULES AND METHOD FOR THE PRODUCTION AND USE THEREOF

The present invention is directed to a method for producing environmentally friendly microcapsules. Moreover, the present invention provides microcapsules obtained/obtainable by the method according to the invention, in particular multilayer microcapsules which are suitable for all kinds of industrial application, in particular in personal care and home care products. The microcapsules preferably comprise at least one oil as core material.

Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them
10638750 · 2020-05-05 · ·

The present invention relates to compositions comprising a hollow glucan particle or cell wall particle encapsulating a terpene component, methods of their manufacture and their use. The compositions are suitable for preventing and treating infections in plants and animals, including humans.